Skip to main content
Livermore
Livermore
ZHEN

Werlinich Asset Management, LLC

SEC CIK
0002000493
Latest filing
Jul 9, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Werlinich Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of ABT by Werlinich Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−19,935−100.0%Sold outHolders
Q1 202619,935$2.05M1.0%+4,290+27.4%AddedHolders
Q4 202515,645$1.97M1.0%+1,275+8.9%AddedHolders
Q3 202514,370$1.92M1.0%+600+4.4%AddedHolders
Q2 202513,770$1.87M1.0%00.0%UnchangedHolders
Q1 202513,770$1.83M1.2%00.0%UnchangedHolders
Q4 202413,770$1.55M0.9%+75+0.5%AddedHolders
Q3 202413,695$1.56M0.9%+100+0.7%AddedHolders
Q2 202413,595$1.42M0.9%+150+1.1%AddedHolders
Q1 202413,445$1.53M1.0%−50.0%ReducedHolders
Q4 202313,450$1.48M1.1%−384−2.8%ReducedHolders
Q3 202313,834$1.34M1.1%+274+2.0%AddedHolders
Q2 202313,560$1.48M1.2%+500+3.8%AddedHolders
Q1 202313,060$1.32M1.2%+50+0.4%AddedHolders
Q4 202213,010$1.43M1.3%−350−2.6%ReducedHolders
Q3 202213,360$1.29M1.3%−200−1.5%ReducedHolders
Q2 202213,560$1.47M1.4%00.0%UnchangedHolders
Q1 202213,560$1.60M1.2%−305−2.2%ReducedHolders
Q4 202113,865$1.95M1.4%00.0%UnchangedHolders
Q3 202113,865$1.64M1.3%00.0%UnchangedHolders
Q2 202113,865$1.61M1.3%+100+0.7%AddedHolders
Q1 202113,765$1.65M1.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.